Scarica l'app Stockscreener
1.46
0.68%
-0.01
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché BBLG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.47
Aprire:
$1.53
Volume 24 ore:
465.86K
Relative Volume:
10.88
Capitalizzazione di mercato:
$2.62M
Reddito:
-
Utile/perdita netta:
$-2.86M
Rapporto P/E:
-0.5823
EPS:
-2.5071
Flusso di cassa netto:
$-2.57M
1 W Prestazione:
+14.96%
1M Prestazione:
+16.80%
6M Prestazione:
-21.38%
1 anno Prestazione:
-72.45%
Intervallo 1D:
$1.36
$1.53
Intervallo di 1 settimana:
$1.22
$1.54
Portata 52W:
$1.05
$6.75
Bone Biologics Corp Stock (BBLG) Company Profile
Nome
Bone Biologics Corp
Settore
Industria
Telefono
(781) 552-4452
Indirizzo
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
1.46 | 2.62M | 0 | -2.86M | -2.57M | -2.5071 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Bone Biologics Corp Borsa (BBLG) Ultime notizie
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp (BBLG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bone Biologics Corp (BBLG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bone Biologics Corp (BBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bone Biologics Corp (BBLG) Institutional Confidence - TradingKey
Bone Biologics Corp (BBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bone Biologics Corp (BBLGW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bone Biologics Corp (BBLGW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bone Biologics Corp (BBLGW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bone Biologics Corp (BBLGW) Institutional Confidence - TradingKey
Bone Biologics Corp (BBLGW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics Corp (BBLGW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp (BBLGW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss Offers Some Relief as Pipeline Progress ContinuesEPS Estimate Trend - newsline.com
Bone Biologics Corp (BBLGW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BBLG | Bone Biologics Corp Common Insider Trading - Quiver Quantitative
BBLG Q1 2026 Earnings: EPS Beat on Narrower Loss, Stock Dips SlightlyDiluted EPS Report - newsline.com
Bone Biologics Corp (BBLG) Edges Lower Amid Light Trading – Key Support Level in FocusBreadth Thrust - newsline.com
Bone Biologics Corp (BBLG) Edges Lower in Quiet Trading, Holding Above $1.19 SupportBear Flag - newsline.com
Bone Biologics Corp Warrants (BBLGW) Remains Steady at $14.0, Navigating Key Support and Resistance LevelsEnding Diagonal - newsline.com
Bone Biologics Corp Warrants (BBLGW) Surge Over 9%: Key Levels and OutlookOBV Trend Line - newsline.com
Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Asia Demineralized Bone Matrix Allograft MaterialsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss Per ShareRevenue Miss Report - newsline.com
Bone Biologics Corp (BBLG) Edges Higher as Stock Tests Key Technical LevelsATR Stop - newsline.com
NUWE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
World Demineralized bone matrix allograft materialsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
BBLG Q1 2026 Earnings: Smaller-than-Expected Loss on No Revenue as Bone Graft Developer Continues R&D ProgressGAAP Earnings Report - The Legal Advocate
BBLG Q1 2026 Earnings: Narrower Loss Surprises as Bone Biologics Advances Pre-Clinical PipelineEarnings Recovery Stocks - newsline.com
Bone Biologics Corp (BBLG) Surges 5.24% — Can It Hold Above Key Resistance?Factor Rotation - The Legal Advocate
Bone Biologics Corp (BBLG) Tests Support After Marginal DeclineSize Factor - newsline.com
Bone Biologics Corp (BBLG) Rises 3.28% as Stock Approaches Resistance LevelFundamental Weighted - The Legal Advocate
Bone Biologics Corp Warrants (BBLGW) Holding Steady at $14.15 After a Flat SessionBullish Pattern Stocks - The Legal Advocate
World Bone Graft SubstitutesMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss as Company Advances Bone Graft PlatformROIC Trend Report - Newser
BBLG Q1 2026 Earnings: Narrowed Loss Beats Estimates as Bone Biologics Advances PipelineBook Value Growth - The Legal Advocate
BBLG Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue; Stock DeclinesAI Trading Community - Newser
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares DipSocial Signal Watchlist - Newser
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss as Bone Biologics Advances DevelopmentFree Stock Community - Newser
Bone Biologics extends rhNELL-1 protein shelf life to 29 months - Investing.com
Spine fusion protein from Bone Biologics now lasts 29 months - Stock Titan
Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1 - Yahoo Finance
VBIO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
VBIO PE Ratio & Valuation, Is VBIO Overvalued - Intellectia AI
Bone Biologics (BBLG) flags going concern, cash runway into Q4 2026 - Stock Titan
TradingKey - TradingKey
Bone Biologics Corp expected to post a loss of 54 cents a shareEarnings Preview - TradingView
Bone Biologics Corp Azioni (BBLG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):